CVE-2024-49574
SQL Injection
Zohocorp ManageEngine ADAudit Plus versions below 8123 are vulnerable to SQL Injection in the reports module.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- Low
Exploit likelihood
What each source reports
CVE List Score used
SQL Injection
Zohocorp ManageEngine ADAudit Plus versions below 8123 are vulnerable to SQL Injection in the reports module.
- Record
CVE-2024-49574- CVSS 3.1
- 8.3 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L - Weakness
- CWE-89
- Updated
- 2026-11-02
EUVDEUVD-2024-43726
Zohocorp ManageEngine ADAudit Plus versions below 8123 are vulnerable to SQL Injection in the reports module.
- Record
EUVD-2024-43726- CVSS 3.1
- 8.3 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L - Updated
- 2026-11-03
GitHub AdvisoriesGHSA-rc9f-q3jv-fx7r
Zohocorp ManageEngine ADAudit Plus versions below 8123 are vulnerable to SQL Injection in the...
Zohocorp ManageEngine ADAudit Plus versions below 8123 are vulnerable to SQL Injection in the reports module.
- Record
GHSA-rc9f-q3jv-fx7r- CVSS 3.1
- 8.3 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L - Weakness
- CWE-89
- Updated
- 2026-11-02
NVD
Zohocorp ManageEngine ADAudit Plus versions below 8123 are vulnerable to SQL Injection in the reports module.
- Record
CVE-2024-49574- CVSS 3.1
- 8.3 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L - CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-89
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases, published | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2024-49574 is a high vulnerability (CVSS 8.3) in Manageengine Adaudit Plus, published November 18, 2024. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 3.62%, the 89th percentile. No source names a fixed version.